buy digital currency with paypal, snippets

 KBW upgraded Societe Generale to outperform the broader market with a target price of 32 euros.With the intensive IPO process of domestic semiconductor companies, we can seize new opportunities in the semiconductor chip industry through the semiconductor ETF(512480). On December 11th, the semiconductor ETF(512480) closed up 0.20% with a turnover of 1.29 billion yuan. The constituent stocks are mixed. In terms of rising, the Cambrian led the rise, and Weir shares followed. In terms of decline, Zhongwei Company led the decline, and Haiguang Information followed suit. In the news, in the fourth quarter of 2024, the IPO acceptance review in science and technology innovation board has been accelerated, with 12 companies updating their review status, mostly in the semiconductor industry. According to industry insiders, from the current audit dynamics, materials, parts and components in the upstream of the industry, as well as AI chips in the design process, may be more popular in the future. Guojin Securities pointed out that semiconductor self-control is the general trend, and it is optimistic about semiconductor equipment parts, materials and domestic computing power industry chain. CITIC Securities said that it is expected that the overall localization pace of the domestic semiconductor industry will be further accelerated, and the manufacturing sector is also expected to benefit. Investors can take advantage of the semiconductor ETF(512480) to grasp the new opportunities in the semiconductor chip industry.

Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.The Taiwan Affairs Office of the State Council introduced the situation of the 2024 Shanghai-Taipei Twin Cities Forum. The Taiwan Affairs Office held a regular press conference. Spokesperson Zhu Fenglian said that it is understood that the 2024 Shanghai-Taipei Urban Forum will be held in Taipei on December 17, and Shanghai will send a delegation to Taiwan to attend the forum. With the theme of "Smart Governance for a Sustainable Future", the forum will promote the interactive exchanges between the two cities in terms of friendly transportation, river governance and humanistic cities. During the forum, the two cities will also sign a memorandum on exchanges and cooperation. We hope the forum will be successful.Governor of Belgorod, Russia: Ukrainian troops fired more than 30 shells in Belgorod within 24 hours, causing no casualties or property losses.

The interest rate of active bonds of 10-year and 30-year treasury bonds went down by more than 2bp, and the yield of main inter-bank interest bonds went down. The interest rate of 10-year treasury bonds went down by 2.15bp to 1.82%. The interest rate of 30-year national debt 2400006 fell by 2.15bp to 2.3075%; In 10 years, the interest rate of CDB 240215 dropped by 2.65bp to 1.886%.Changhong Meiling: It plans to use its own idle funds not exceeding 6.35 billion yuan to invest in wealth management products. Changhong Meiling announced that in order to improve the efficiency of the company's use of funds, increase the company's cash assets income, and maximize the interests of shareholders, the company and its subsidiaries (excluding Zhongke Meiling Cryogenic Technology Co., Ltd. and its subsidiaries) will use their own idle funds not exceeding 6.35 billion yuan (this amount can be used in a rolling way) to invest and purchase products with high safety, good liquidity and a term of less than one year.On the 11th, CSI 1000 index futures rose by 1.01%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract CSI 1000 index futures closed at 2,412, up or down by +1.01%, with a turnover of 147,000 lots. The position data showed that the top 20 seats were clear, and the difference position was 7,210 lots. The total number of contracts of CSI 1000 index futures was 235,100 lots, a decrease of 70,300 lots from the previous day. The first 20 seats in the contract held 237,700 lots, a decrease of 17,700 lots from the previous day. The short positions in the top 20 seats of the contract were 266,100 lots, a decrease of 16,500 lots from the previous day. (Sina Futures)